摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-chlorophenyl)-2-(1-p-tolylethylidene)hydrazine | 386272-18-0

中文名称
——
中文别名
——
英文名称
1-(4-chlorophenyl)-2-(1-p-tolylethylidene)hydrazine
英文别名
——
1-(4-chlorophenyl)-2-(1-p-tolylethylidene)hydrazine化学式
CAS
386272-18-0
化学式
C15H15ClN2
mdl
——
分子量
258.75
InChiKey
RLVHUFBXHLQGHW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    369.9±52.0 °C(Predicted)
  • 密度:
    1.10±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.48
  • 重原子数:
    18.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    24.39
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    描述:
    1-(4-chlorophenyl)-2-(1-p-tolylethylidene)hydrazine 在 sodium hydroxide 、 三氯氧磷 作用下, 以 甲醇 为溶剂, 反应 15.5h, 生成 5-{[1-(4-chlorophenyl)-3-(p-tolyl)-1H-pyrazol-4-yl]methylene}-2-imino-3-[2-methyl-3-(tri-fluoromethyl)phenyl]thiazolidin-4-one
    参考文献:
    名称:
    Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids
    摘要:
    AbstractIn the present investigation, we devolved and synthesized a new series of pyrazole‐embedded thiazolidin‐4‐one derivatives (9a–p) with the goal to produce promising antitubercular leads. The in vitro antimycobacterial activity of the synthesized compounds was tested against replicating and nonreplicating Mtb H37Rv strains. With MIC ranging from 3.03 to 22.55 µg/ml, five compounds (9a, 9c, 9d, 9e, and 9f) emerged as promising antitubercular agents. The active molecules were nontoxic to normal Vero cells. All the synthesized compounds were evaluated for in vitro anti‐inflammatory studies. Compounds 9a, 9b, 9c, 9h, and 9i exhibited excellent anti‐inflammatory efficacy. Docking study was performed to understand the binding pattern of the significantly active compound 9a with 1P44.
    DOI:
    10.1002/ardp.202200444
  • 作为产物:
    描述:
    对氯苯肼盐酸盐对甲基苯乙酮溶剂黄146 、 sodium hydroxide 作用下, 反应 1.0h, 生成 1-(4-chlorophenyl)-2-(1-p-tolylethylidene)hydrazine
    参考文献:
    名称:
    1,3,4-Trisubstituted pyrazole bearing a 4-(chromen-2-one) thiazole: synthesis, characterization and its biological studies
    摘要:
    3-{2-[N′-(1,3-二取代-1H-吡唑-4-基-甲基)-肼基]-噻唑-4-基}-香豆素-2-酮类化合物(10a-l)被合成、表征并用于对抗各种微生物的体外抗菌研究。大多数化合物具有生物活性。
    DOI:
    10.1039/c5ra04995d
点击查看最新优质反应信息

文献信息

  • Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents
    作者:Fatma A. Ragab、Nagwa M. Abdel Gawad、Hanan H. Georgey、Mona F. Said
    DOI:10.1016/j.ejmech.2013.03.005
    日期:2013.5
    Some novel 1,3,4-trisubstituted pyrazoles were synthesized and screened for their anti-inflammatory and analgesic activities as well as their ulcerogenic liability. They showed anti-inflammatory and analgesic activities with better GIT tolerance than the standard drug phenylbutazone. In addition, IC50 values for 5e and 8e were recorded. Compound 5e was found to be the most active one as anti-inflammatory
    合成了一些新颖的1,3,4-三取代吡唑,并筛选了它们的抗炎和镇痛活性以及致溃疡作用。他们显示出比标准药物苯基丁a具有更好的GIT耐受性的抗炎和镇痛活性。另外,记录了5e和8e的IC 50值。发现化合物5e作为抗炎和止痛剂是最活性的。另一方面,还进行了COX-1 / COX-2同工酶的选择性,对两种同工型均表现出相同的抑制作用。
  • Novel pyrazole‐clubbed thiophene derivatives via Gewald synthesis as antibacterial and anti‐inflammatory agents
    作者:Soukhyarani G. Nayak、Boja Poojary、Vinuta Kamat
    DOI:10.1002/ardp.202000103
    日期:2020.12
    Schiff bases by condensing 2amino‐5‐(2,4‐dichlorophenyl)thiophene‐3‐carbonitrile and 1,3‐disubstituted‐1H‐pyrazole‐4‐carbaldehydes, and to investigate their biological activity. The compounds were synthesized via Gewald synthesis and characterized by spectral data and elemental analyses. They were screened for their in vitro antibacterial and antiinflammatory activities. The synthesized compounds
    本研究的目的是通过缩合 2-基-5-(2,4-二氯苯基)噻吩-3-甲腈和 1,3-二取代-1H-吡唑-4-甲醛来合成新的有效席夫碱,并研究它们的生物活性。这些化合物是通过 Gewald 合成法合成的,并通过光谱数据和元素分析进行​​表征。筛选了它们的体外抗菌和抗炎活性。还使用微孔板 Alamar Blue 测定评估了合成的化合物对结核分枝杆菌 H37Rv 的体外抗结核活性。化合物 8b、8c、8f、8g、8k、8n 和 8o 显示出良好的抗菌活性。取代的吡唑与牛蛋白之间的相互作用显示出有希望的抗炎活性。实验结果表明化合物 8a 是一种很有前景的抗结核药物。溶血试验证实这些化合物是无毒的,溶血百分比范围为 3.6 至 20.1,浓度为 1 毫克/毫升。结果表明,吡唑环和杂环部分上的取代模式对生物活性有影响。
  • Antitubercular and Antimicrobial Activity of NH4VO3 Promoted 1,4- Dihydropyridine Incorporated 1,3,4-trisubstituted Pyrazole
    作者:Nandam Harikrishna、Arun M. Isloor、K. Ananda、Tanya Parish、Joazaizulfazli Jamalis、Hazem A. Ghabbour、Hoong-Kun Fun
    DOI:10.2174/1570180813666161103145224
    日期:2017.6.6
    synthesized from substituted acetylated aryls and substituted phenylhydrazine by the multistep reaction. Method: The target compounds 1,4-dihydropyridine derivatives were obtained from green synthesis of 1,3-disubstituted phenyl-1H-pyrazole-4-carbaldehydes 4a-i with ethyl acetoacetate and methyl acetoacetate at higher temperatures in the presence of ammonium acetate and the catalytic amount of ammonium metavanadate
    背景:以取代乙酰化芳基和取代苯为原料,通过多步反应合成了一系列含有 1,4-二氢吡啶衍生物 5a-i 和 6a-i 的新型吡唑。方法: 目标化合物 1,4-二氢吡啶衍生物由 1,3-二取代苯基-1H-吡唑-4-甲醛 4a-i 与乙酰乙酸乙酯乙酰乙酸甲酯在较高温度下在醋酸偏钒酸铵(NH4VO3)的催化量。偏钒酸铵的作用是提高反应速率并获得高产率。结果:新合成的含有吡唑生物的 1,4-二氢吡啶部分的结构通过 FT-IR、NMR 和质谱研究得到证实。通过S-XRD研究证实了化合物5b的结构。更多,对这些化合物进行了体外抗结核和抗微生物研究。发现化合物 5a、5b、5i、6a、6b、6g、6h 和 6i 对所有细菌微生物都有活性。结论:上述化合物对结核分枝杆菌的最低 MIC 在 3.12-12.5 μg/ml 之间,对耻垢分枝杆菌、黄色葡萄球菌和绿假单胞菌的 MIC 值在 7.8-15
  • Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study
    作者:Fateme Azimi、Homa Azizian、Mohammad Najafi、Farshid Hassanzadeh、Hojjat Sadeghi-aliabadi、Jahan B. Ghasemi、Mohammad Ali Faramarzi、Somayeh Mojtabavi、Bagher Larijani、Lotfollah Saghaei、Mohammad Mahdavi
    DOI:10.1016/j.bioorg.2021.105127
    日期:2021.9
    structure–activity relationship suggested that the variation in the inhibitory activities of the compounds affected by different substitutions on phenyl rings of diphenyl pyrazole moiety. The enzyme kinetic studies of the most potent compound 9i revealed that it inhibited α-glucosidase in a competitive mode with a Ki of 56 μM. Molecular docking study was performed to predict the putative binding interaction. As expected
    在这项研究中,设计、合成了一系列新的喹唑啉酮-吡唑杂化物,并筛选了它们的 α-葡萄糖苷酶抑制活性。的结果在体外筛选表明所有分子杂交显示出更多的抑制活性(IC 50值从60.5±0.3μM-186.6±20μM范围)相比于标准阿卡波糖(IC 50 = 750.0 ± 10.0 µM)。有限的构效关系表明化合物抑制活性的变化受二苯基吡唑部分苯环上不同取代的影响。最有效的化合物 9i 的酶动力学研究表明,它以竞争模式抑制 α-葡萄糖苷酶,Ki 为 56 μM。进行分子对接研究以预测假定的结合相互作用。正如预期的那样,初始结构设计中使用的所有药效基团在与酶结合位点的相互作用中都发挥着关键作用。此外,通过进行分子动力学研究和 MM-GBSA 计算,
  • Synthesis of 3-(1, 3-Diphenyl-1<i>H</i>-pyrazol-4-yl) Propanoic Acids Using Diimide Reduction
    作者:M. Deepa、V. Harinadha Babu、R. Parameshwar、B. Madhava Reddy
    DOI:10.1155/2012/481682
    日期:——

    Pyrazole-1H-4-yl-acrylic acids (3a-j) were prepared from pyrazole-1H-4-carbaldehydes which in turn were prepared by the Vilsmeier-Haack reaction of phenyl hydrazone derivatives (1a-j). The reaction of pyrazole-1H-4-yl-acrylic acids to 3-(1, 3-diphenyl-1H-pyrazol-4-yl) propanoic acids (4a-j) was carried out using Pd-charcoal and diimide methods and % yields were compared. Though the yields may be slightly less in diimide method, the method was found to be economical, highly effective with simple operating procedure.

    从苯基腙衍生物(1a-j)的Vilsmeier-Haack反应制备的吡唑-1H-4-基丙烯酸(3a-j)制备而成的吡唑-1H-4-基丙烯酸(3a-j)制备自吡唑-1H-4-羰基醛。使用Pd-木和二亚甲基方法进行吡唑-1H-4-基丙烯酸反应制备3-(1,3-二苯基-1H-吡唑-4-基)丙酸(4a-j),并比较产率。尽管二亚甲基方法的产率可能略低,但该方法被证明在操作程序简单的情况下经济高效。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫